idocaine (lignocaine) for Neuropathic Cancer Pain – Feasibility study (LiCPain)
Phase 2
- Conditions
- europathic Cancer Pain
- Registration Number
- ACTRN12617000747325
- Lead Sponsor
- niversity of Technology Sydney
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method